Novel Immune Checkpoints in Esophageal Cancer: From Biomarkers to Therapeutic Targets

Esophageal cancer ranks as the sixth most common cause of cancer death worldwide. Due to the limited efficacy of conventional therapeutic strategies, including surgery, chemotherapy, and radiotherapy, treatments are still far from satisfactory in terms of survival, prompting the search for novel tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Xueyin, Ren, Ting, Zan, Hongyuan, Hua, Chunyan, Guo, Xufeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163322/
https://www.ncbi.nlm.nih.gov/pubmed/35669786
http://dx.doi.org/10.3389/fimmu.2022.864202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9163322/
https://www.ncbi.nlm.nih.gov/pubmed/35669786
http://dx.doi.org/10.3389/fimmu.2022.864202

Ejemplares similares